相关实验视频

Updated: Jul 6, 2025

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

干扰素治疗改善了治疗性手术后B型肝炎病毒相关肝细胞癌患者的存活率:元分析

Jian-Xing Luo^1,2, Yang Zhang^1,2, Xiao-Yu Hu^3,4

¹Department of Infectious Diseases, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.

Hepatology international

|January 2, 2024

概括

干扰素治疗显示出在手术后改善B型肝炎病毒相关肝细胞癌患者的生存率和减少复发的潜力. 然而,它的长期益处可能会随着时间的推移而减少.

科学领域:

肝病学肝病学是一种肝病学.
在瘤学瘤学.
病毒学病毒学

背景情况:

肝细胞癌 (HCC) 是一个主要的全球健康问题,特别是在乙型肝炎病毒 (HBV) 流行率高的地区.
之前关于干扰素在与HBV相关的HCC中有效性的研究已经产生了相互矛盾的结果.
需要澄清干扰素在改善HBV相关HCC治疗后手术的结果中的作用.

研究的目的:

重新评估干扰素在改善整体存活率 (OS) 和减少治疗手术后与HBV相关的HCC患者的复发方面的疗效.
综合来自多项研究的证据,以提供对干扰素益处的全面评估.

主要方法:

进行了系统的元分析.
搜索了主要的生物医学数据库,包括MEDLINE/PubMed,Cochrane图书馆,EMBASE,科学网和CNKI.
包括10项试验,共2062名被诊断患有与HBV相关的HCC的患者接受了治疗性手术.

主要成果:

干扰素显著改善了1年,2年,3年和5年的整体存活率 (OS) 和1年,2年和3年的无病存活率 (DFS).
干扰素显著降低了2年,3年和5年的复发率.
没有观察到8年OS或5年DFS的显著改善,并且1年复发率没有降低.

结论:

干扰素可能在减少复发和改善DFS和OS方面提供显著的短期到中期好处,用于手术后与HBV相关的HCC患者.
干扰素的疗效优势似乎在较长的随访期间逐渐减弱.
需要进一步的研究来探索干扰素的最佳临床应用,可能与核类同类 (NA) 结合使用.

关键词:

临床研究是临床研究.没有疾病的生存率.国际货币基金组织 IFN IFN 肝癌是一种肝癌.肝脏瘤是什么肝脏瘤是什么核酸类型的类似物.总的说来,总体生存率是很高的.复发情况复发情况切除切除切除切除这是TACE的税率.

更多相关视频

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...